Fig. 6From: Synergistic cytoprotection by co-treatment with dexamethasone and rapamycin against proinflammatory cytokine-induced alveolar epithelial cell injuryThe effect of dexamethasone or rapamycin on phosphorylation of Akt or c-Jun. a A549 cells were pretreated with dexamethasone (D) or rapamycin (R) at the indicated concentration for 1Â h and then stimulated with CM. Total cell lysate was collected 24Â h (upper panel) or 48Â h (lower panel) after CM stimulation and then subjected to western blotting using the indicated antibody. The effect of combination of dexamethasone (10Â nM) and rapamycin (1Â nM) surpassed that of 10 times concentration of each drug in terms of the inhibition of iNOS, cox2, cleaved caspase 7, and phosphorylated H2AX. In addition, both of augmentation of phosphorylated Akt (p-Akt) and inhibition of phosphorylated c-Jun (p-c-Jun) were remarkable in combined treatment of dexamethasone and rapamycin. b A549 cells were pretreated with dexamethasone (10Â nM, D), rapamycin (1Â nM, R) or both (10Â nM D/1Â nM R) for 1Â h and then stimulated with BSA (vehicle control) or CM. Total cell lysate was collected 24Â h after stimulation and then subjected to western blotting using the indicated antibodyBack to article page